ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Breast Cancer
Squamous Cell Carcinoma of Head and Neck

Lung Cancer trials near Columbus, OH, USA:

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Columbus, Ohio, United States and 72 other locations

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Active, not recruiting
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

Columbus, Ohio, United States and 33 other locations

Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized ...

Enrolling
Extensive Stage Lung Small Cell Cancer
Drug: Ivonescimab 20 mg/kg
Drug: Ivonescimab 10 mg/kg

Phase 2

PrECOG

Columbus, Ohio, United States and 12 other locations

type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Sunvozertinib

Phase 1, Phase 2

Dizal Pharma

Columbus, Ohio, United States and 124 other locations

This phase II trial tests the effect of tarlatamab in treating patients with small-cell lung cancer (SCLC) that has spread from whe...

Enrolling
Extensive Stage Lung Small Cell Carcinoma
Other: Electronic Health Record Review
Procedure: Computed Tomography

Phase 2

Asrar Alahmadi

Columbus, Ohio, United States

This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung ...

Enrolling
Stage IVA Lung Cancer AJCC v8
Recurrent Lung Small Cell Carcinoma
Drug: Temozolomide
Biological: Atezolizumab

Phase 2

Dwight Owen

Columbus, Ohio, United States and 4 other locations

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer ...

Enrolling
Small Cell Lung Cancer
Drug: Alisertib

Phase 2

Puma Biotechnology
Puma Biotechnology

Columbus, Ohio, United States of America and 29 other locations

growth factor A (VEGF-A) in participants with non-small cell lung cancer (NSCLC).The study will comprise several cohorts for dose ...

Enrolling
Non-Small Cell Lung Cancer
Biological: BNT116
Biological: Bispecific antibody for PD-L1 and VEGF-A

Phase 1

BioNTech
BioNTech

Columbus, Ohio, United States and 46 other locations

or cisplatin, for the first-line treatment of adult participants with KRAS G12C-mutated, advanced or metastatic non squamous non-small cell lung...

Enrolling
KRAS G12C Lung Cancer
Non-Small Cell Lung Cancer
Drug: Cisplatin
Drug: Pemetrexed

Phase 3

Roche
Roche

Columbus, Ohio, United States and 279 other locations

The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS...

Active, not recruiting
Small-Cell Lung Cancer
Extensive-Stage Small-Cell Lung Cancer
Drug: Tarlatamab
Drug: Durvalumab

Phase 3

Amgen
Amgen

Columbus, Ohio, United States and 223 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems